BOOTHBAY FUND MANAGEMENT, LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 124 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$425,723
-8.9%
30,2360.0%0.01%
-10.0%
Q1 2023$467,146
-57.5%
30,236
-54.9%
0.01%
-60.0%
Q4 2022$1,098,425
-44.4%
67,018
-37.2%
0.02%
-49.0%
Q3 2022$1,974,000
+141.3%
106,689
+27.5%
0.05%
+157.9%
Q4 2021$818,000
-73.8%
83,663
-8.9%
0.02%
-77.9%
Q3 2021$3,121,000
+1114.4%
91,843
+1208.9%
0.09%
+975.0%
Q2 2021$257,000
-59.8%
7,017
-77.0%
0.01%
-91.4%
Q4 2018$639,000
+31.5%
30,454
+142.6%
0.09%
+93.8%
Q3 2018$486,00012,5520.05%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders